Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 114,401 | 100,279 | 157,614 | 159,040 | 183,815 |
| Marketable Securities | 174,711 | 207,029 | 168,489 | 186,467 | 193,428 |
| Receivables | 18,537 | 18,197 | 18,484 | 13,857 | 3,434 |
| TOTAL | $312,255 | $330,814 | $350,131 | $363,961 | $384,955 |
| Non-Current Assets | |||||
| PPE Net | 30,331 | 30,168 | 31,085 | 28,280 | 26,360 |
| Investments And Advances | 16,783 | 20,541 | 23,614 | 27,999 | 0 |
| Intangibles | 38,550 | 40,815 | 39,830 | 39,424 | 38,264 |
| Other Non-Current Assets | 468 | 468 | 468 | 5,467 | 13,980 |
| TOTAL | $86,132 | $91,992 | $94,997 | $101,170 | $78,604 |
| Total Assets | $398,387 | $422,806 | $445,128 | $465,131 | $463,559 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 992 | 1,847 | 1,150 | 1,479 | 2,813 |
| Accrued Expenses | 12,911 | 12,445 | 18,499 | 17,865 | 11,121 |
| Other current liabilities | 6,799 | 7,172 | 6,829 | N/A | N/A |
| TOTAL | $38,315 | $36,346 | $41,401 | $34,289 | $28,879 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 17,613 | 14,882 | 14,923 | 14,945 | 14,945 |
| Other Non-Current Liabilities | 1,778 | 1,831 | 1,577 | 7,624 | 7,299 |
| TOTAL | $183,638 | $189,501 | $166,254 | $174,428 | $176,940 |
| Total Liabilities | $221,953 | $225,847 | $207,655 | $208,717 | $205,819 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,812 | 15,746 | 16,201 | 15,461 | 14,922 |
| Common Shares | 8 | 8 | 8 | 8 | 7 |
| Retained earnings | -355,065 | -330,667 | -283,863 | -257,731 | -233,211 |
| Other shareholders' equity | 1,179 | 2,621 | 1,893 | 1,701 | 608 |
| TOTAL | $176,434 | $196,959 | $237,473 | $256,414 | $257,740 |
| Total Liabilities And Equity | $398,387 | $422,806 | $445,128 | $465,131 | $463,559 |